Article info
Editorial
Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation?
- Correspondence to Dr Jonathan P Piccini, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27710, USA; jonathan.piccini{at}duke.edu
Citation
Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation?
Publication history
- First published May 29, 2015.
Online issue publication
August 12, 2015
Article Versions
- Previous version (29 May 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions